Campanelli Paul
EVP, Pres-Par Pharmaceutical at PAR PHARMACEUTICAL COMPANIES, INC.
- Sold, on record
- $6.4M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Mar 8, 2011
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- PAR PHARMACEUTICAL COMPANIES, INC.EVP, Pres-Par Pharmaceutical
Sales by reason
0
Routine
3
Plan not stated
0
No plan
2
Unusual
Form 4 sales per year, every sale on record.
Timeline
- Mar 8, 2011Unusual
PAR PHARMACEUTICAL COMPANIES, INC.
Sold 44.4% of their holdings
$1.5M47,720 shares at $30.73
- Mar 8, 2011Plan not stated
PAR PHARMACEUTICAL COMPANIES, INC.
Sold 12.3% of their holdings
$466k15,068 shares at $30.90
- Mar 7, 2011Unusual
PAR PHARMACEUTICAL COMPANIES, INC.
Sold 46.3% of their holdings
$3.2M105,647 shares at $30.76
- Mar 2, 2010Plan not stated
PAR PHARMACEUTICAL COMPANIES, INC.
Sold 16.9% of their holdings
$623k24,885 shares at $25.04
- Aug 24, 2009Plan not stated
PAR PHARMACEUTICAL COMPANIES, INC.
Sold 21.3% of their holdings
$632k31,234 shares at $20.25
5 of 5
Every transaction
| Traded | Filed | Stock | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|
| Oct 7, 2022 | Oct 12, 2022 | Convey Holding Parent, Inc. | Director | Returned to the companyRestricted Stock Units | 27,125 | 0 | SEC | ||
| Mar 28, 2022 | Mar 30, 2022 | Convey Holding Parent, Inc. | Director | AwardedRestricted Stock Units | 27,125 | 27,125 | SEC | ||
| Apr 6, 2021 | Apr 6, 2021 | Endo International plc | Director | Exercised options | 668,300 | 1.8M | SEC | ||
| Apr 6, 2021 | Apr 6, 2021 | Endo International plc | Director | Withheld for tax | 334,784 | $7.37 | $2.5M | 1.6M | SEC |
| Mar 29, 2021 | Mar 31, 2021 | Endo International plc | Director | Withheld for tax | 72,926 | $7.31 | $533k | 1.3M | SEC |
| Aug 10, 2020 | Aug 12, 2020 | Endo International plc | Director | Withheld for tax | 116,789 | $3.40 | $397k | 1.2M | SEC |
| Apr 2, 2020 | Apr 6, 2020 | Endo International plc | Director | Withheld for tax | 146,400 | $3.16 | $463k | 1.1M | SEC |
| Mar 29, 2020 | Mar 31, 2020 | Endo International plc | Director | Withheld for tax | 72,926 | $3.52 | $257k | 921,385 | SEC |
| Feb 25, 2020 | Feb 25, 2020 | Endo International plc | President, CEO | Exercised options | 435,875 | 937,847 | SEC | ||
| Feb 25, 2020 | Feb 25, 2020 | Endo International plc | President, CEO | Withheld for tax | 118,158 | $6.19 | $731k | 844,871 | SEC |
| Sep 28, 2019 | Oct 1, 2019 | Endo International plc | President, CEO | Withheld for tax | 1,874 | $3.12 | $6k | 675,829 | SEC |
| Aug 10, 2019 | Aug 13, 2019 | Endo International plc | President, CEO | Withheld for tax | 116,790 | $2.49 | $291k | 673,862 | SEC |
| Apr 2, 2019 | Apr 4, 2019 | Endo International plc | President, CEO | Withheld for tax | 146,400 | $8.10 | $1.2M | 551,326 | SEC |
| Mar 31, 2019 | Apr 2, 2019 | Endo International plc | President, CEO | Awarded | 448,318 | 2M | SEC | ||
| Feb 23, 2019 | Feb 26, 2019 | Endo International plc | President, CEO | Withheld for tax | 998 | $10.51 | $10k | 397,726 | SEC |
| Feb 21, 2019 | Feb 25, 2019 | Endo International plc | President, CEO | Withheld for tax | 24,184 | $10.38 | $251k | 395,769 | SEC |
| Sep 28, 2018 | Oct 2, 2018 | Endo International plc | President, CEO | Withheld for tax | 1,801 | $16.71 | $30k | 344,138 | SEC |
| Aug 10, 2018 | Aug 14, 2018 | Endo International plc | President, CEO | Withheld for tax | 70,180 | $15.82 | $1.1M | 342,097 | SEC |
| Jul 31, 2018 | Aug 2, 2018 | Endo International plc | President, CEO | Awarded | 290,476 | 1.8M | SEC | ||
| Apr 2, 2018 | Apr 4, 2018 | Endo International plc | President, CEO | Awarded | 900,000 | 1.5M | SEC | ||
| Feb 23, 2018 | Feb 27, 2018 | Endo International plc | President, CEO | Withheld for tax | 942 | $6.78 | $6k | 269,777 | SEC |
| Feb 21, 2018 | Feb 22, 2018 | Endo International plc | President, CEO | Withheld for tax | 24,184 | $6.72 | $163k | 267,763 | SEC |
| Sep 28, 2017 | Oct 2, 2017 | Endo International plc | President, CEO | Withheld for tax | 1,330 | $8.38 | $11k | 216,132 | SEC |
| Aug 14, 2017 | Aug 15, 2017 | Endo International plc | President, CEO | Bought | 6,500 | $7.71 | $50k | 213,620 | SEC |
| Aug 10, 2017 | Aug 11, 2017 | Endo International plc | President, CEO | Awarded2015 Stock Incentive Plan Stock Options (NQ) | 971,590 | 971,590 | SEC | ||
| Aug 10, 2017 | Aug 11, 2017 | Endo International plc | President, CEO | Awarded | 427,500 | 675,336 | SEC | ||
| Mar 16, 2017 | Mar 16, 2017 | Endo International plc | President, CEO | Bought | 2,300 | $10.72 | $25k | 207,120 | SEC |
| Feb 23, 2017 | Feb 27, 2017 | Endo International plc | President, CEO | Withheld for tax | 1,066 | $13.22 | $14k | 204,820 | SEC |
| Feb 21, 2017 | Feb 23, 2017 | Endo International plc | President, CEO | Awarded2015 Stock Incentive Plan Stock Options (NQ) | 510,204 | 510,204 | SEC | ||
| Feb 21, 2017 | Feb 23, 2017 | Endo International plc | President, CEO | Awarded | 227,445 | 250,792 | SEC | ||
| Sep 28, 2016 | Sep 28, 2016 | Endo International plc | President & CEO | Withheld for tax | 1,981 | $22.26 | $44k | 202,930 | SEC |
| Sep 26, 2016 | Sep 28, 2016 | Endo International plc | President & CEO | Awarded2015 Stock Incentive Plan Stock Options (NQ) | 429,645 | 429,645 | SEC | ||
| May 10, 2016 | May 11, 2016 | Endo International plc | Group President, Generics | Bought | 13,000 | $15.53 | $202k | 201,069 | SEC |
| Feb 23, 2016 | Feb 25, 2016 | Endo International plc | Group President, Generics | Awarded2015 Stock Incentive Plan Stock Options (NQ) | 39,875 | 39,875 | SEC | ||
| Feb 23, 2016 | Feb 25, 2016 | Endo International plc | Group President, Generics | Awarded | 35,467 | 27,189 | SEC | ||
| Nov 11, 2015 | Nov 12, 2015 | Endo International plc | President, Par Pharmaceutical | Bought | 2,100 | $55.69 | $117k | 188,069 | SEC |
| Nov 11, 2015 | Nov 12, 2015 | Endo International plc | President, Par Pharmaceutical | Awarded | 2,100 | 105,466 | SEC | ||
| Nov 3, 2015 | Nov 5, 2015 | Endo International plc | Group President, Generics | Awarded | 72,632 | 103,366 | SEC | ||
| Sep 28, 2015 | Sep 30, 2015 | Endo International plc | Group President, Generics | Awarded2015 Stock Incentive Plan Stock Options (NQ) | 56,920 | 56,920 | SEC | ||
| Sep 28, 2015 | Sep 30, 2015 | Endo International plc | Group President, Generics | Awarded | 46,101 | 30,734 | SEC | ||
| Sep 28, 2012 | Oct 2, 2012 | PAR PHARMACEUTICAL COMPANIES, INC. | Chief Executive Officer | Returned to the companyPerformance Stock Units | 237,836 | $20.81 | $4.9M | 0 | SEC |
| Sep 28, 2012 | Oct 2, 2012 | PAR PHARMACEUTICAL COMPANIES, INC. | Chief Executive Officer | Returned to the company | 46,017 | $50.00 | $2.3M | 0 | SEC |
| Jan 11, 2012 | Jan 13, 2012 | PAR PHARMACEUTICAL COMPANIES, INC. | Chief Operating Officer | Withheld for tax | 1,102 | $35.65 | $39k | 46,106 | SEC |
| Jan 6, 2012 | Jan 9, 2012 | PAR PHARMACEUTICAL COMPANIES, INC. | Chief Operating Officer | Withheld for tax | 806 | $34.01 | $27k | 47,118 | SEC |
| Jan 5, 2012 | Jan 9, 2012 | PAR PHARMACEUTICAL COMPANIES, INC. | Chief Operating Officer | AwardedRestricted Stock Units | 101,751 | 25,438 | SEC | ||
| Jan 4, 2012 | Jan 6, 2012 | PAR PHARMACEUTICAL COMPANIES, INC. | Chief Operating Officer | Withheld for tax | 1,062 | $32.17 | $34k | 47,924 | SEC |
| Nov 21, 2011 | Nov 22, 2011 | PAR PHARMACEUTICAL COMPANIES, INC. | Chief Operating Officer | Withheld for tax | 7,009 | $29.56 | $207k | 49,794 | SEC |
| Mar 22, 2011 | Mar 24, 2011 | PAR PHARMACEUTICAL COMPANIES, INC. | EVP, Pres-Par Pharmaceutical | Withheld for tax | 3,039 | $29.00 | $88k | 56,803 | SEC |
| Mar 8, 2011 | Mar 9, 2011 | PAR PHARMACEUTICAL COMPANIES, INC. | EVP, Pres-Par Pharmaceutical | Sold | 47,720 | $30.73 | $1.5M | 59,842 | SEC |
| Mar 8, 2011 | Mar 9, 2011 | PAR PHARMACEUTICAL COMPANIES, INC. | EVP, Pres-Par Pharmaceutical | Sold | 15,068 | $30.90 | $466k | 107,562 | SEC |
Page 1
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 8, 2011 | Mar 9, 2011 | PAR PHARMACEUTICAL COMPANIES, INC. | EVP, Pres-Par Pharmaceutical | Form 4 sale | 47,720 | $1.5M | 44.4% | Unusual | SEC |
| Mar 8, 2011 | Mar 9, 2011 | PAR PHARMACEUTICAL COMPANIES, INC. | EVP, Pres-Par Pharmaceutical | Form 4 sale | 15,068 | $466k | 12.3% | Plan not stated | SEC |
| Mar 7, 2011 | Mar 9, 2011 | PAR PHARMACEUTICAL COMPANIES, INC. | EVP, Pres-Par Pharmaceutical | Form 4 sale | 105,647 | $3.2M | 46.3% | Unusual | SEC |
| Mar 2, 2010 | Mar 3, 2010 | PAR PHARMACEUTICAL COMPANIES, INC. | EVP; President - Generics | Form 4 sale | 24,885 | $623k | 16.9% | Plan not stated | SEC |
| Aug 24, 2009 | Aug 26, 2009 | PAR PHARMACEUTICAL COMPANIES, INC. | EVP, Pres. - Generics | Form 4 sale | 31,234 | $632k | 21.3% | Plan not stated | SEC |